Does the media prefer ESTA or SSII?

In the previous week, Establishment Labs had 2 more articles in the media than SS Innovations International. MarketBeat recorded 6 mentions for Establishment Labs and 4 mentions for SS Innovations International. Establishment Labs' average media sentiment score of 1.25 beat SS Innovations International's score of 0.71 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SS Innovations International 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer WRBY or SSII?

In the previous week, Warby Parker had 4 more articles in the media than SS Innovations International. MarketBeat recorded 8 mentions for Warby Parker and 4 mentions for SS Innovations International. Warby Parker's average media sentiment score of 1.00 beat SS Innovations International's score of 0.71 indicating that Warby Parker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SS Innovations International 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TMDX or SSII?

In the previous week, TransMedics Group had 2 more articles in the media than SS Innovations International. MarketBeat recorded 6 mentions for TransMedics Group and 4 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 0.71 beat TransMedics Group's score of 0.32 indicating that SS Innovations International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SS Innovations International 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer NVCR or SSII?

In the previous week, NovoCure had 3 more articles in the media than SS Innovations International. MarketBeat recorded 7 mentions for NovoCure and 4 mentions for SS Innovations International. NovoCure's average media sentiment score of 0.89 beat SS Innovations International's score of 0.71 indicating that NovoCure is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NovoCure 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SS Innovations International 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SSII or LMAT?

In the previous week, LeMaitre Vascular had 2 more articles in the media than SS Innovations International. MarketBeat recorded 6 mentions for LeMaitre Vascular and 4 mentions for SS Innovations International. LeMaitre Vascular's average media sentiment score of 0.76 beat SS Innovations International's score of 0.71 indicating that LeMaitre Vascular is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LeMaitre Vascular 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

SS Innovations International (SSII) Competitors

$3.98 -0.01 (-0.25%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$3.97 -0.01 (-0.25%)

As of 07/31/2026 07:53 PM Eastern

Compare

SSII vs. ESTA, WRBY, TMDX, NVCR, and LMAT

Should you buy SS Innovations International stock or one of its competitors? MarketBeat compares SS Innovations International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SS Innovations International include Establishment Labs (ESTA), Warby Parker (WRBY), TransMedics Group (TMDX), NovoCure (NVCR), and LeMaitre Vascular (LMAT).

How does SS Innovations International compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and SS Innovations International (NASDAQ:SSII) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.

Establishment Labs has a net margin of -19.05% compared to SS Innovations International's net margin of -20.69%. SS Innovations International's return on equity of -23.00% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-19.05%	-218.77%	-12.31%
SS Innovations International	-20.69%	-23.00%	-13.18%

Establishment Labs has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.96, meaning that its stock price is 296% less volatile than the broader market.

Establishment Labs currently has a consensus target price of $90.43, suggesting a potential downside of 2.28%. SS Innovations International has a consensus target price of $7.00, suggesting a potential upside of 75.88%. Given SS Innovations International's higher probable upside, analysts plainly believe SS Innovations International is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

72.9% of Establishment Labs shares are held by institutional investors. 10.0% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

SS Innovations International has lower revenue, but higher earnings than Establishment Labs. SS Innovations International is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	12.90	-$51.06M	-$1.49	N/A
SS Innovations International	$42.49M	18.75	-$12.13M	-$0.05	N/A

In the previous week, Establishment Labs had 2 more articles in the media than SS Innovations International. MarketBeat recorded 6 mentions for Establishment Labs and 4 mentions for SS Innovations International. Establishment Labs' average media sentiment score of 1.25 beat SS Innovations International's score of 0.71 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SS Innovations International	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Establishment Labs beats SS Innovations International on 11 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to Warby Parker?

Warby Parker (NYSE:WRBY) and SS Innovations International (NASDAQ:SSII) are related companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Warby Parker presently has a consensus price target of $29.82, indicating a potential upside of 11.84%. SS Innovations International has a consensus price target of $7.00, indicating a potential upside of 75.88%. Given SS Innovations International's higher possible upside, analysts plainly believe SS Innovations International is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Warby Parker	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.64
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

93.2% of Warby Parker shares are owned by institutional investors. 16.8% of Warby Parker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Warby Parker has a net margin of 0.15% compared to SS Innovations International's net margin of -20.69%. Warby Parker's return on equity of 2.30% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Warby Parker	0.15%	2.30%	1.18%
SS Innovations International	-20.69%	-23.00%	-13.18%

Warby Parker has a beta of 1.91, indicating that its share price is 91% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.96, indicating that its share price is 296% less volatile than the broader market.

Warby Parker has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Warby Parker	$871.91M	3.27	$1.64M	$0.02	1,333.10
SS Innovations International	$42.49M	18.75	-$12.13M	-$0.05	N/A

In the previous week, Warby Parker had 4 more articles in the media than SS Innovations International. MarketBeat recorded 8 mentions for Warby Parker and 4 mentions for SS Innovations International. Warby Parker's average media sentiment score of 1.00 beat SS Innovations International's score of 0.71 indicating that Warby Parker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Warby Parker	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
SS Innovations International	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Warby Parker beats SS Innovations International on 14 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and SS Innovations International (NASDAQ:SSII) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

TransMedics Group has a net margin of 27.04% compared to SS Innovations International's net margin of -20.69%. TransMedics Group's return on equity of 22.38% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransMedics Group	27.04%	22.38%	8.46%
SS Innovations International	-20.69%	-23.00%	-13.18%

TransMedics Group currently has a consensus target price of $129.55, indicating a potential upside of 69.32%. SS Innovations International has a consensus target price of $7.00, indicating a potential upside of 75.88%. Given SS Innovations International's higher probable upside, analysts clearly believe SS Innovations International is more favorable than TransMedics Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

TransMedics Group has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$605.49M	4.37	$190.29M	$4.40	17.39
SS Innovations International	$42.49M	18.75	-$12.13M	-$0.05	N/A

TransMedics Group has a beta of 1.89, indicating that its share price is 89% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.96, indicating that its share price is 296% less volatile than the broader market.

In the previous week, TransMedics Group had 2 more articles in the media than SS Innovations International. MarketBeat recorded 6 mentions for TransMedics Group and 4 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 0.71 beat TransMedics Group's score of 0.32 indicating that SS Innovations International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransMedics Group	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SS Innovations International	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.7% of TransMedics Group shares are owned by institutional investors. 6.9% of TransMedics Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

TransMedics Group beats SS Innovations International on 13 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to NovoCure?

NovoCure (NASDAQ:NVCR) and SS Innovations International (NASDAQ:SSII) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

NovoCure has a beta of 0.94, suggesting that its share price is 6% less volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.96, suggesting that its share price is 296% less volatile than the broader market.

84.6% of NovoCure shares are owned by institutional investors. 5.5% of NovoCure shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, NovoCure had 3 more articles in the media than SS Innovations International. MarketBeat recorded 7 mentions for NovoCure and 4 mentions for SS Innovations International. NovoCure's average media sentiment score of 0.89 beat SS Innovations International's score of 0.71 indicating that NovoCure is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NovoCure	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SS Innovations International	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SS Innovations International has lower revenue, but higher earnings than NovoCure. SS Innovations International is trading at a lower price-to-earnings ratio than NovoCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NovoCure	$655.35M	2.64	-$136.23M	-$1.30	N/A
SS Innovations International	$42.49M	18.75	-$12.13M	-$0.05	N/A

NovoCure currently has a consensus price target of $21.20, indicating a potential upside of 42.86%. SS Innovations International has a consensus price target of $7.00, indicating a potential upside of 75.88%. Given SS Innovations International's higher probable upside, analysts clearly believe SS Innovations International is more favorable than NovoCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NovoCure	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

SS Innovations International has a net margin of -20.69% compared to NovoCure's net margin of -21.25%. SS Innovations International's return on equity of -23.00% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NovoCure	-21.25%	-44.00%	-15.85%
SS Innovations International	-20.69%	-23.00%	-13.18%

Summary

NovoCure beats SS Innovations International on 9 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to LeMaitre Vascular?

SS Innovations International (NASDAQ:SSII) and LeMaitre Vascular (NASDAQ:LMAT) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

SS Innovations International presently has a consensus price target of $7.00, suggesting a potential upside of 75.88%. LeMaitre Vascular has a consensus price target of $112.60, suggesting a potential upside of 11.13%. Given SS Innovations International's higher probable upside, equities analysts plainly believe SS Innovations International is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.56

84.6% of LeMaitre Vascular shares are owned by institutional investors. 7.4% of LeMaitre Vascular shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

LeMaitre Vascular has a net margin of 24.35% compared to SS Innovations International's net margin of -20.69%. LeMaitre Vascular's return on equity of 15.36% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-20.69%	-23.00%	-13.18%
LeMaitre Vascular	24.35%	15.36%	9.78%

SS Innovations International has a beta of -1.96, suggesting that its share price is 296% less volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market.

LeMaitre Vascular has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	18.75	-$12.13M	-$0.05	N/A
LeMaitre Vascular	$249.60M	9.28	$57.73M	$2.71	37.39

In the previous week, LeMaitre Vascular had 2 more articles in the media than SS Innovations International. MarketBeat recorded 6 mentions for LeMaitre Vascular and 4 mentions for SS Innovations International. LeMaitre Vascular's average media sentiment score of 0.76 beat SS Innovations International's score of 0.71 indicating that LeMaitre Vascular is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

LeMaitre Vascular beats SS Innovations International on 14 of the 16 factors compared between the two stocks.

Get SS Innovations International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SSII vs. The Competition

Export

Metric	SS Innovations International	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$796.53M	$5.67B	$7.17B	$12.47B
Dividend Yield	N/A	1.79%	2.60%	10.03%
P/E Ratio	-79.60	23.11	282.25	24.53
Price / Sales	18.75	57.07	584.88	90.62
Price / Cash	N/A	32.07	71.23	59.99
Price / Book	19.90	6.31	11.09	5.90
Net Income	-$12.13M	$148.76M	$3.50B	$336.31M
7 Day Performance	14.70%	1.77%	-0.24%	0.09%
1 Month Performance	1.02%	5.34%	-2.97%	-5.67%
1 Year Performance	-35.81%	2.08%	61.94%	18.79%

SS Innovations International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SSII SS Innovations International	1.6627 of 5 stars	$3.98 -0.3%	$7.00 +75.9%	-41.4%	$796.53M	$42.49M	N/A	4
ESTA Establishment Labs	1.9996 of 5 stars	$92.32 +1.3%	$90.43 -2.0%	+120.5%	$2.68B	$229.58M	N/A	1,004	News Coverage Positive News Upcoming Earnings
WRBY Warby Parker	3.2366 of 5 stars	$24.53 +0.9%	$29.82 +21.6%	+11.5%	$2.63B	$890.57M	1,226.86	4,036	News Coverage Upcoming Earnings
TMDX TransMedics Group	4.4384 of 5 stars	$72.26 +1.6%	$134.50 +86.1%	-35.7%	$2.46B	$635.89M	16.42	210	Upcoming Earnings Analyst Forecast
NVCR NovoCure	3.3586 of 5 stars	$17.65 -11.7%	$21.20 +20.1%	+28.3%	$2.32B	$674.41M	N/A	1,605	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SSII) was last updated on 8/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SS Innovations International (SSII) Competitors

SSII vs. ESTA, WRBY, TMDX, NVCR, and LMAT

How does SS Innovations International compare to Establishment Labs?

Summary

How does SS Innovations International compare to Warby Parker?

Summary

How does SS Innovations International compare to TransMedics Group?

Summary

How does SS Innovations International compare to NovoCure?

Summary

How does SS Innovations International compare to LeMaitre Vascular?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSII vs. The Competition

SS Innovations International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SS Innovations International (SSII) Competitors

SSII vs. ESTA, WRBY, TMDX, NVCR, and LMAT

How does SS Innovations International compare to Establishment Labs?

Is ESTA or SSII more profitable?

Which has more risk & volatility, ESTA or SSII?

Do analysts rate ESTA or SSII?

Do institutionals and insiders have more ownership in ESTA or SSII?

Which has stronger earnings & valuation, ESTA or SSII?

Does the media prefer ESTA or SSII?

Summary

How does SS Innovations International compare to Warby Parker?

Do analysts prefer WRBY or SSII?

Do insiders and institutionals have more ownership in WRBY or SSII?

Is WRBY or SSII more profitable?

Which has more volatility and risk, WRBY or SSII?

Which has stronger valuation and earnings, WRBY or SSII?

Does the media prefer WRBY or SSII?

Summary

How does SS Innovations International compare to TransMedics Group?

Is TMDX or SSII more profitable?

Do analysts prefer TMDX or SSII?

Which has better earnings & valuation, TMDX or SSII?

Which has more volatility & risk, TMDX or SSII?

Does the media prefer TMDX or SSII?

Do insiders & institutionals have more ownership in TMDX or SSII?

Summary

How does SS Innovations International compare to NovoCure?

Which has more risk & volatility, NVCR or SSII?

Do insiders and institutionals have more ownership in NVCR or SSII?

Does the media prefer NVCR or SSII?

Which has better valuation and earnings, NVCR or SSII?

Do analysts recommend NVCR or SSII?

Is NVCR or SSII more profitable?

Summary

How does SS Innovations International compare to LeMaitre Vascular?

Do analysts rate SSII or LMAT?

Do institutionals and insiders have more ownership in SSII or LMAT?

Is SSII or LMAT more profitable?

Which has more volatility & risk, SSII or LMAT?

Which has stronger valuation and earnings, SSII or LMAT?

Does the media favor SSII or LMAT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSII vs. The Competition

SS Innovations International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools